Marshall Wace has taken a £150 million bet against the wellbeing of Haleon, the FTSE 100 consumer healthcare company that was spun out of GSK. It is the first time that a short-seller of Haleon has been identified since its separate listing two years ago.
The London-based hedge fund co-founded by Sir Paul Marshall, the GB News backer, has built a net short position equating to about 0.52 per cent of Haleon’s £30 billion market capitalisation, filings with the Financial Conduct Authority show.
“Shorting” is a technique that enables investors to profit from falling prices and the move by Marshall Wace, one of the world’s biggest hedge funds with $65 billion of assets under management, suggests it expects Haleon’s stock to decline. It is the